Breaking News Instant updates and real-time market news.

2020-06-05 05:03:24 HUM Humana $391.89 / -1.08 (-0.27%) 05:03 06/05/20 06/05 05:03 06/05/20 05:03	Humana initiated with a Buy at Goldman Sachs Goldman Sachs analyst Robert Jones initiated coverage of Humana with a Buy rating and $510 price target. Despite facing some newer entrants in the Medicare Advantage market, Humana's scale, brand reputation and provider infrastructure set the company up well to continue to gain share in the fastest growing vertical of managed care, Jones tells investors in a research note. The business is even more attractive currently given Medicare Advantage's relative insulation from COVID-19 impacts, adds the analyst. He sees "potentially room for multiple expansion" at current Humana share levels.
HUM Humana $391.89 / -1.08 (-0.27%) 06/01/20 Stephens Molina Healthcare price target raised to $215 from $202 at Stephens 05/21/20 Truist SunTrust raises price targets across select Healthcare Services names 05/04/20 Mizuho Humana price target raised to $420 from $405 at Mizuho 04/30/20 Credit Suisse Humana price target raised to $423 from $400 at Credit Suisse

2020-06-05 05:03:24

HUM

Humana

$391.89 / -1.08 (-0.27%)

05:03

06/05/20

06/05

05:03

06/05/20

05:03

Humana initiated with a Buy at Goldman Sachs

Goldman Sachs analyst Robert Jones initiated coverage of Humana with a Buy rating and $510 price target. Despite facing some newer entrants in the Medicare Advantage market, Humana's scale, brand reputation and provider infrastructure set the company up well to continue to gain share in the fastest growing vertical of managed care, Jones tells investors in a research note. The business is even more attractive currently given Medicare Advantage's relative insulation from COVID-19 impacts, adds the analyst. He sees "potentially room for multiple expansion" at current Humana share levels.

HUM Humana

$391.89 / -1.08 (-0.27%)

06/01/20 Stephens: Molina Healthcare price target raised to $215 from $202 at Stephens

05/21/20 Truist: SunTrust raises price targets across select Healthcare Services names

05/04/20 Mizuho: Humana price target raised to $420 from $405 at Mizuho

04/30/20 Credit Suisse: Humana price target raised to $423 from $400 at Credit Suisse

TODAY'S FREE FLY STORIES

Syndicate	Patria indicated to open at $22, IPO priced at $17 11:28 01/22/21 01/22 11:28 01/22/21 11:28 PAX Patria $0.00 / + (+0.00%) ShowHide Related Items >><< Syndicate 22 Jan
Initiation	Canada Goose initiated with a Hold at Williams Trading » 11:28 01/22/21 01/22 11:28 01/22/21 11:28 GOOS Canada Goose $31.81 / +0.12 (+0.38%) Williams Trading analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options GOOS Canada Goose $31.81 / +0.12 (+0.38%) 11/05/20 Canada Goose reports Q2 DTC revenue in mainland China up over 30% 09/30/20 Canada Goose rises 10.2% 08/11/20 Canada Goose is not providing FY21 outlook GOOS Canada Goose $31.81 / +0.12 (+0.38%) 01/05/21 BTIG Canada Goose price target lowered to C$31 from C$35 at BTIG 12/10/20 Goldman Sachs Canada Goose downgraded to Sell from Neutral at Goldman Sachs 11/25/20 Fly Intel: Top five analyst downgrades 11/25/20 BTIG Canada Goose double-downgraded to Sell from Buy at BTIG GOOS Canada Goose $31.81 / +0.12 (+0.38%) 11/05/20 Canada Goose not providing FY21 guidance 11/05/20 Canada Goose reports Q2 adj EPS C$10c vs. C$57c last year 08/11/20 Canada Goose reports Q1 adjusted EPS (C$0.35) vs. (C$0.21) last year 08/11/20 Canada Goose reports Q1 EPS C$46c compared to C$27c GOOS Canada Goose $31.81 / +0.12 (+0.38%) 11/25/20 Fly Intel: Pre-market Movers 10/27/20 Foot Locker, DocuSign initiations among today's top calls on Wall Street 09/30/20 Starbucks, Shopify upgrades among today's top calls on Wall Street 08/11/20 Fly Intel: Pre-market Movers GOOS Canada Goose $31.81 / +0.12 (+0.38%) 10/21/20 Canada Goose put volume heavy and directionally bearish 10/12/20 Canada Goose put volume heavy and directionally bearish
Periodicals	YouTube enables HDR support on Xbox gaming systems, Verge reports » 11:27 01/22/21 01/22 11:27 01/22/21 11:27 GOOG Alphabet $1,908.96 / +19.11 (+1.01%) , GOOGL Alphabet Class A $1,902.03 / +19.63 (+1.04%) , MSFT Microsoft $229.52 / +4.63 (+2.06%) Alphabet's (GOOGL)… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options GOOG GOOGL MSFT GOOG Alphabet $1,908.96 / +19.11 (+1.01%) 06:03 Today Alphabet announces plans to wind down Loon 01/19/21 Google Cloud launches Product Discovery Solutions for Retail 01/17/21 Fly Intel: Top five weekend stock stories 01/14/21 Google completes acquisition of Fitbit, commits to protect users' privacy GOOGL Alphabet Class A $1,902.03 / +19.63 (+1.04%) 06:03 Today Alphabet announces plans to wind down Loon 01/19/21 Google Cloud launches Product Discovery Solutions for Retail 01/17/21 Fly Intel: Top five weekend stock stories 01/14/21 Google completes acquisition of Fitbit, commits to protect users' privacy MSFT Microsoft $229.52 / +4.63 (+2.06%) 10:46 Today Microsoft increases pricing for Xbox Live Gold 09:03 Today SAP, Microsoft expand partnership 01/20/21 EU fines Valve, Capcom, ZeniMax, others EUR7.8M for 'geo-blocking' practices 01/19/21 General Motors jumps 6% to $53.25 after Microsoft invests in Cruise GOOG GOOGL MSFT GOOG Alphabet $1,908.96 / +19.11 (+1.01%) 01/21/21 Fly Intel: Top five analyst initiations 01/20/21 Piper Sandler Alphabet assumed with an Overweight at Piper Sandler 01/19/21 JPMorgan JPMorgan says buy 'FANG' stocks amid 'fatigue and frustration' 01/15/21 MoffettNathanson Alphabet price target raised to $2,100 from $1,900 at MoffettNathanson GOOGL Alphabet Class A $1,902.03 / +19.63 (+1.04%) 01/21/21 Fly Intel: Top five analyst initiations 01/20/21 Piper Sandler Alphabet assumed with an Overweight at Piper Sandler 01/19/21 JPMorgan JPMorgan says buy 'FANG' stocks amid 'fatigue and frustration' 01/19/21 KeyBanc Alphabet price target to $2,060 from $1,970 at KeyBanc MSFT Microsoft $229.52 / +4.63 (+2.06%) 09:31 Today RBC Capital Varonis price target raised to $200 from $165 at RBC Capital 01/21/21 Goldman Sachs Microsoft initiated with a Buy at Goldman Sachs 01/21/21 Cleveland Research Microsoft demand beat expectations in December quarter, says Cleveland Research 01/21/21 Evercore ISI Evercore boosts Microsoft target, adds to 'tactical outperform list' GOOG GOOGL MSFT GOOG Alphabet $1,908.96 / +19.11 (+1.01%) 10/29/20 Alphabet reports Q3 Traffic Acquisition Costs $8.17B vs. $7.49B a year ago 10/29/20 Alphabet reports Q3 Google Cloud revenue $3.44B vs. $2.38B a year ago 10/29/20 Alphabet reports Q3 Google advertising revenue $37.1B vs. $33.8B a year ago 10/29/20 Alphabet reports Q3 EPS $16.40, consensus $11.29 GOOGL Alphabet Class A $1,902.03 / +19.63 (+1.04%) 10/29/20 Alphabet CFO sees signs user behavior beginning to return to normalized level 10/29/20 Alphabet reports Q3 Traffic Acquisition Costs $8.17B vs. $7.49B a year ago 10/29/20 Alphabet reports Q3 Google Cloud revenue $3.44B vs. $2.38B a year ago 10/29/20 Alphabet reports Q3 Google advertising revenue $37.1B vs. $33.8B a year ago MSFT Microsoft $229.52 / +4.63 (+2.06%) 10/27/20 Microsoft sees Q2 Productivity and Business Processes revenue $12.75B-$13B 10/27/20 Microsoft reports Q1 EPS $1.82, consensus $1.54 10/27/20 Notable companies reporting after market close 07/22/20 Microsoft reports Q4 EPS $1.46, consensus $1.37 GOOG GOOGL MSFT GOOG Alphabet $1,908.96 / +19.11 (+1.01%) 10:42 Today Waymo CEO: Tesla Autopilot will fall short of full autonomy, Bloomberg reports 06:11 Today Google threatens to close search engine in Australia over news plans, FT reports 01/20/21 Trump pardons engineer Google said stole secrets for Uber, Ars Technica says 01/20/21 EU seeks info from advertisers about Google's ad tech practices, Reuters says GOOGL Alphabet Class A $1,902.03 / +19.63 (+1.04%) 10:42 Today Waymo CEO: Tesla Autopilot will fall short of full autonomy, Bloomberg reports 06:11 Today Google threatens to close search engine in Australia over news plans, FT reports 01/20/21 EU seeks info from advertisers about Google's ad tech practices, Reuters says 01/20/21 Google probes actions of ethical AI leader Margaret Mitchell, Axios reports MSFT Microsoft $229.52 / +4.63 (+2.06%) 01/19/21 FireEye releases tool for auditing networks after SolarWinds hack, ZDNet says 01/14/21 IBM buying cloud computing consultant Taos Mountain, WSJ reports 01/13/21 Lucasfilm partners with Ubisoft to make open-world 'Star Wars' game, Wired says 01/12/21 Microsoft, others near deals for prime office space in Florida, BI reports GOOG GOOGL MSFT GOOG Alphabet $1,908.96 / +19.11 (+1.01%) 01/21/21 Snap initiation, PayPal upgrade among today's top calls on Wall Street 01/20/21 #SocialStocks: Facebook could be in focus under new administration 01/19/21 Game On: An exclusive talk with The Game Bakers' Emeric Thoa 01/13/21 #SocialStocks: Social Media cancels Trump, Amazon cuts off Parler GOOGL Alphabet Class A $1,902.03 / +19.63 (+1.04%) 01/21/21 Snap initiation, PayPal upgrade among today's top calls on Wall Street 01/20/21 #SocialStocks: Facebook could be in focus under new administration 01/19/21 Game On: An exclusive talk with The Game Bakers' Emeric Thoa 01/13/21 #SocialStocks: Social Media cancels Trump, Amazon cuts off Parler MSFT Microsoft $229.52 / +4.63 (+2.06%) 09:34 Today Disney, Ford upgrades among today's top calls on Wall Street 01/19/21 Fly Intel: Wall Street's top stories for Tuesday 01/19/21 Fly Intel: Wall Street's top stories at midday 01/19/21 Game On: An exclusive talk with The Game Bakers' Emeric Thoa 01/26/21 Pharmacovigilance & Risk Management Strategies Virtual Conference 02/11/21 Technology & Internet Virtual Conference 01/26/21 Microsoft - MSFT 02/02/21 Alphabet Class A - GOOGL 02/02/21 Alphabet - GOOG GOOG GOOGL MSFT GOOG Alphabet $1,908.96 / +19.11 (+1.01%) 11/10/20 Alphabet call volume above normal and directionally bullish 10/30/20 Early notable gainers among liquid option names on October 30th GOOGL Alphabet Class A $1,902.03 / +19.63 (+1.04%) 01/20/21 Early notable gainers among liquid option names on January 20th 10/30/20 Early notable gainers among liquid option names on October 30th 10/21/20 Unusually active option classes on open October 21st 08/27/20 Alphabet Class A call volume above normal and directionally bullish MSFT Microsoft $229.52 / +4.63 (+2.06%) 12/17/20 Notable open interest changes for December 17th 11/11/20 Notable open interest changes for November 11th 10/28/20 Notable open interest changes for October 28th 10/27/20 Notable open interest changes for October 27th
Periodicals	SQM shareholders approve $1.1B stock sale, Reuters reports » 11:25 01/22/21 01/22 11:25 01/22/21 11:25 SQM SQM $56.75 / -0.48 (-0.84%) Shareholders of SQM voted… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals On The Fly SQM SQM $56.75 / -0.48 (-0.84%) 10/04/20 Fly Intel: Top five weekend stock stories SQM SQM $56.75 / -0.48 (-0.84%) 12/16/20 SQM upgraded to Outperform at BMO Capital on high lithium price leverage 12/16/20 BMO Capital SQM upgraded to Outperform from Market Perform at BMO Capital 10/21/20 HSBC SQM upgraded to Buy from Hold at HSBC 10/15/20 Deutsche Bank SQM price target raised to $30 from $28 at Deutsche Bank SQM SQM $56.75 / -0.48 (-0.84%) 10/03/20 Albemarle, SQM among best lithium stocks to play EV boom, Barron's says SQM SQM $56.75 / -0.48 (-0.84%) 09/23/20 Tesla, lithium names under pressure as Wall Street digests Battery Day
Options	Takeda Pharmaceutical call volume above normal and directionally bullish » 11:25 01/22/21 01/22 11:25 01/22/21 11:25 TAK Takeda Pharmaceutical $18.07 / +0.77 (+4.45%) Bullish option flow… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals On The Fly Events TAK Takeda Pharmaceutical $18.07 / +0.77 (+4.45%) 01/21/21 Moderna announces 1st participant dosed in Japan study of Moderna COVID vaccine 12/18/20 Takeda confirms FDA approval of sNDA for Iclusig 12/16/20 Takeda Pharma, Prime Therapeutics sign arrangement for Hemophilia A treatment 12/15/20 FDA accept Takeda NDA for TAK-721, 'specifically' designed for EoE TAK Takeda Pharmaceutical $18.07 / +0.77 (+4.45%) 12/29/20 Needham Needham names Phathom Pharmaceuticals Top Pick for 2021 12/15/20 Needham Phathom Pharmaceuticals price target raised to $55 from $45 at Needham 06/18/20 RBC Capital Neurocrine price target raised to $135 from $116 at RBC Capital 06/17/20 Oppenheimer Takeda deal expands Neurocrine's pipeline into psychiatry, says Oppenheimer TAK Takeda Pharmaceutical $18.07 / +0.77 (+4.45%) 10/09/20 Takeda, others testing convalescent plasma treatment in Covid, WSJ reports 09/01/20 NIH says not enough evidence to recommend convalescent plasma, Bloomberg reports 09/01/20 NIH panel says data fail to back EUA for convalescent plasma, Bloomberg reports 08/19/20 Takeda plans to sell OTC drug unit to Blackstone for $2.3B, Nikkei reports TAK Takeda Pharmaceutical $18.07 / +0.77 (+4.45%) 08/24/20 Fly Intel: Wall Street's top stories for Monday 08/24/20 Fly Intel: Wall Street's top stories at midday 08/24/20 Plasma producers spike after EUA issued for convalescent plasma to treat COVID 08/24/20 Fly Intel: Pre-market Movers 02/08/21 17th Annual Virtual WORLDSymposium 2021 03/01/21 41st Annual Healthcare Virtual Conference 01/29/21 Takeda Pharmaceutical Company Ltd

General news	Energy Action: WTI crude » 11:25 01/22/21 01/22 11:25 01/22/21 11:25 Energy Action: WTI crude… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial
Conference/Events	JPMorgan autos/auto parts analysts hold an analyst/industry conference call » 11:25 01/22/21 01/22 11:25 01/22/21 11:25 Autos & Auto Parts… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial
Initiation	Boot Barn initiated with a Buy at Williams Trading » 11:24 01/22/21 01/22 11:24 01/22/21 11:24 BOOT Boot Barn $57.88 / +0.19 (+0.33%) Williams Trading analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events BOOT Boot Barn $57.88 / +0.19 (+0.33%) 01/08/21 Boot Barn not providing Q4, FY21 guidance amid COVID-19 uncertainty 10/28/20 Boot Barn says Q3 'started well' retail store SSS improving to flat 08/14/20 Boot Barn promotes Greg Hackman to COO 08/05/20 Boot Barn rises 16.6% BOOT Boot Barn $57.88 / +0.19 (+0.33%) 01/14/21 JPMorgan Boot Barn price target raised to $63 from $60 at JPMorgan 01/12/21 Cowen Boot Barn price target raised to $65 from $47 at Cowen 01/11/21 Craig-Hallum Boot Barn price target raised to $48 from $34 at Craig-Hallum 01/11/21 Wells Fargo Boot Barn price target raised to $57 from $49 at Wells Fargo BOOT Boot Barn $57.88 / +0.19 (+0.33%) 01/08/21 Boot Barn reports preliminary Q3 EPS $1.00, consensus 83c 10/28/20 Boot Barn reports Q2 EPS 20c, consensus 12c 08/04/20 Boot Barn reports Q1 EPS (2c), consensus (17c) BOOT Boot Barn $57.88 / +0.19 (+0.33%) 01/06/21 Before the Move: Analysts make pre-announcement predictions ahead of ICR event 11/17/20 American initiation, Moderna downgrade among today's top calls on Wall Street 10/28/20 Fly Intel: After-Hours Movers 08/04/20 Fly Intel: After-Hours Movers 01/25/21 Boot Barn - BOOT
Initiation	Skechers initiated with a Hold at Williams Trading » 11:22 01/22/21 01/22 11:22 01/22/21 11:22 SKX Skechers $36.27 / -0.46 (-1.25%) Williams Trading analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options SKX Skechers $36.27 / -0.46 (-1.25%) 10/29/20 Skechers not providing guidance due to pandemic 07/23/20 Skechers not providing financial guidance given substantial uncertainty SKX Skechers $36.27 / -0.46 (-1.25%) 01/15/21 B. Riley Securities Skechers price target raised to $44 from $39 at B. Riley Securities 12/10/20 Deutsche Bank Skechers price target raised to $43 from $38 at Deutsche Bank 11/03/20 Susquehanna Skechers downgraded to Neutral from Positive at Susquehanna 10/27/20 Fly Intel: Top five analyst initiations SKX Skechers $36.27 / -0.46 (-1.25%) 10/29/20 Skechers reports Q3 EPS 53c, consensus 36c 07/23/20 Skechers reports Q2 EPS (44c), consensus (66c) 07/23/20 Notable companies reporting after market close SKX Skechers $36.27 / -0.46 (-1.25%) 10/29/20 Fly Intel: After-Hours Movers 10/27/20 Foot Locker, DocuSign initiations among today's top calls on Wall Street 07/24/20 Fly Intel: Pre-market Movers 07/23/20 Fly Intel: After-Hours Movers SKX Skechers $36.27 / -0.46 (-1.25%) 10/28/20 Skechers call volume above normal and directionally bullish 09/25/20 Unusual call flow in option market yesterday 09/24/20 Buyers slip into Skechers November calls 07/23/20 Skechers options imply 14.5% move in share price post-earnings
Initiation	VF Corp. initiated with a Buy at Williams Trading » 11:20 01/22/21 01/22 11:20 01/22/21 11:20 VFC VF Corp. $83.48 / -0.71 (-0.84%) Williams Trading analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options VFC VF Corp. $83.48 / -0.71 (-0.84%) 01/11/21 VF Corp. to move Asia Pacific operations to Shanghai from Hong Kong 12/28/20 VF Corp. completes previously announced 'modestly accretive' Supreme acquisition 11/11/20 VF Corp. CEO says dealt with questions like those about Supreme with prior deals 11/11/20 VF Corp. CEO says Supreme 'very complementary' to other portfolio brands VFC VF Corp. $83.48 / -0.71 (-0.84%) 01/21/21 Deutsche Bank VF Corp. upgraded to Buy from Hold at Deutsche Bank 01/21/21 Deutsche Bank VF Corp. upgraded to Buy from Hold at Deutsche Bank 01/11/21 OTR Global VF Corp. upgraded to Positive from Mixed at OTR Global 01/07/21 JPMorgan VF Corp. price target raised to $100 from $88 at JPMorgan VFC VF Corp. $83.48 / -0.71 (-0.84%) 10/16/20 VF Corp. sees FY21 adjusted EPS 'at least' $1.20, consensus $1.12 10/16/20 VF Corp. reports Q2 adjusted cont ops EPS 67c, consensus 49c 10/15/20 Notable companies reporting before tomorrow's open 10/15/20 Notable companies reporting before tomorrow's open VFC VF Corp. $83.48 / -0.71 (-0.84%) 11/03/20 McDonald's appoints Reginald Miller as new diversity chief, AP reports VFC VF Corp. $83.48 / -0.71 (-0.84%) 11/17/20 American initiation, Moderna downgrade among today's top calls on Wall Street 10/19/20 UnitedHealth downgrade, Tesla target raise among top calls on Wall Street 10/16/20 Fly Intel: Pre-market Movers 10/06/20 Beyond Meat boosted by Piper Sandler teen survey results 01/27/21 VF Corp. - VFC VFC VF Corp. $83.48 / -0.71 (-0.84%) 08/28/20 Unusually active option classes on open August 28th

Recommendations	Extendicare price target lowered to C$6.50 from C$7 at National Bank » 11:19 01/22/21 01/22 11:19 01/22/21 11:19 EXETF Extendicare $0.00 / + (+0.00%) National Bank analyst Tal… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research EXETF Extendicare $0.00 / + (+0.00%) 11/19/20 National Bank Extendicare price target raised to C$7 from C$6 at National Bank 08/18/20 RBC Capital Extendicare price target lowered to C$7 from C$7.50 at RBC Capital 07/30/20 CIBC Extendicare price target lowered to C$7 from C$8 at CIBC 05/22/20 RBC Capital Extendicare price target lowered to C$7.50 from C$7.75 at RBC Capital
Periodicals	Citron Research no longer commenting on GameStop » 11:19 01/22/21 01/22 11:19 01/22/21 11:19 GME GameStop $47.18 / +4.2 (+9.77%) Andrew Left's Citron… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options GME GameStop $47.18 / +4.2 (+9.77%) 01/20/21 GameStop falls -6.7% 01/19/21 GameStop rises 24.6% 01/17/21 Fly Intel: Top five weekend stock stories 01/15/21 December video game spending grew 25% y/y to $7.7B, says NPD GME GameStop $47.18 / +4.2 (+9.77%) 01/13/21 Standpoint Research GameStop downgraded to Hold from Buy at Standpoint Research 01/11/21 Benchmark Benchmark 'not surprised' by GameStop board change after 'disappointing' holiday 12/09/20 Benchmark GameStop price target lowered to $5 from $6 at Benchmark 12/04/20 Wedbush GameStop price target raised to $16 from $8 at Wedbush GME GameStop $47.18 / +4.2 (+9.77%) 12/08/20 GameStop reports Q3 adj. EPS (53c), consensus (85c) 12/08/20 GameStop reports Q3 EPS (29c), consensus (85c) 12/08/20 Notable companies reporting after market close 09/09/20 GameStop reports Q2 adj. EPS ($1.40), consensus ($1.13) GME GameStop $47.18 / +4.2 (+9.77%) 01/19/21 Citron sees five reasons GameStop will trade 'back to $20 fast' 01/16/21 GameStop stock double last week, challenges remain, Barron's says 01/09/21 GameStop caught in vicious cycle, Barron's says 01/04/21 GameStop added to long side of Investing Ideas list at Hedgeye GME GameStop $47.18 / +4.2 (+9.77%) 01/19/21 Game On: An exclusive talk with The Game Bakers' Emeric Thoa 01/12/21 Game On: Roblox files for direct listing as GameStop adds new directors 01/05/21 Game On: Nintendo buys 'Luigi's Mansion 3' developer Next Level Games 12/22/20 Game On: Sony pulls buggy 'Cyberpunk 2077' from PS Store GME GameStop $47.18 / +4.2 (+9.77%) 01/19/21 Largest borrow rate increases among liquid names 01/14/21 Notable open interest changes for January 14th 01/13/21 GameStop call volume above normal and directionally bullish 01/13/21 Largest borrow rate increases among liquid names
Initiation	Crocs initiated with a Buy at Williams Trading » 11:19 01/22/21 01/22 11:19 01/22/21 11:19 CROX Crocs $73.80 / +0.01 (+0.01%) Williams Trading analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events CROX Crocs $73.80 / +0.01 (+0.01%) 01/11/21 Crocs rises after guiding to 'accelerated' 2021 revenue growth of 20%-25% 12/04/20 Crocs announces Post Malone x Crocs Duet Max Clog II 12/02/20 Crocs CEO sells 40K shares of common stock 11/02/20 Crocs CEO sells 50K shares of common stock CROX Crocs $73.80 / +0.01 (+0.01%) 01/19/21 Loop Capital Crocs price target raised to $90 from $75 at Loop Capital 01/13/21 Monness Crespi Crocs price target raised to $91 from $60 at Monness Crespi 01/12/21 B. Riley Securities Crocs price target raised to $87 from $72 at B. Riley Securities 01/12/21 Stifel Crocs price target raised to $76 from $56 at Stifel CROX Crocs $73.80 / +0.01 (+0.01%) 10/27/20 Crocs reports Q3 EPS 91c, consensus 69c 10/26/20 Notable companies reporting before tomorrow's open 10/26/20 Notable companies reporting before tomorrow's open 09/11/20 Crocs sees Q3 revenue up 10% from 3Q19 revenue of $312.8M, consensus $305.19M CROX Crocs $73.80 / +0.01 (+0.01%) 09/12/20 Crocs stock could double, Barron's says CROX Crocs $73.80 / +0.01 (+0.01%) 01/06/21 Before the Move: Analysts make pre-announcement predictions ahead of ICR event 10/27/20 Fly Intel: Pre-market Movers 10/06/20 Beyond Meat boosted by Piper Sandler teen survey results 10/01/20 Fly Intel: Wall Street's top stories for Thursday 03/11/21 Crocs
Initiation	Deckers Brands initiated with a Buy at Williams Trading » 11:18 01/22/21 01/22 11:18 01/22/21 11:18 DECK Deckers Brands $320.00 / -3.19 (-0.99%) Williams Trading analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly DECK Deckers Brands $320.00 / -3.19 (-0.99%) 07/28/20 Deckers Brands division, Cotopaxi collaborate on sustainable collection DECK Deckers Brands $320.00 / -3.19 (-0.99%) 01/21/21 UBS Deckers Brands price target raised to $400 from $388 at UBS 01/13/21 BTIG Deckers Brands price target raised to $412 from $307 at BTIG 12/11/20 Raymond James Deckers Brands initiated with a Market Perform at Raymond James 12/11/20 Raymond James Deckers Brands initiated with a Market Perform at Raymond James DECK Deckers Brands $320.00 / -3.19 (-0.99%) 10/29/20 Deckers Brands not providing full year guidance for fiscal year 2021 10/29/20 Deckers Brands reports Q2 EPS $3.58, consensus $2.63 07/30/20 Deckers Brands not providing full year guidance for fiscal year 2021 07/30/20 Deckers Brands reports Q1 EPS (28c), consensus ($1.11) DECK Deckers Brands $320.00 / -3.19 (-0.99%) 10/29/20 Fly Intel: After-Hours Movers
Initiation	Nike initiated with a Buy at Williams Trading » 11:17 01/22/21 01/22 11:17 01/22/21 11:17 NKE Nike $139.95 / -1.62 (-1.14%) Williams Trading analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options NKE Nike $139.95 / -1.62 (-1.14%) 12/18/20 Nike says experienced 80% growth in Nike digital this quarter 12/17/20 Hibbett Sports announces partnership with Nike and footwear news site NiceKicks 11/20/20 Nike increases quarterly cash dividend 12% to 27.5c per share 11/13/20 Third Point takes stake in PG&E, boosts Alibaba stake, exits Baxter NKE Nike $139.95 / -1.62 (-1.14%) 12/30/20 Guggenheim Nike named best apparel idea for 2021 at Guggenheim 12/24/20 UBS UBS calls Nike top pick, says momentum 'likely not peaked' 12/22/20 Argus Nike price target raised to $165 from $140 at Argus 12/21/20 Jefferies Nike price target raised to $140 from $117 at Jefferies NKE Nike $139.95 / -1.62 (-1.14%) 12/18/20 Nike raises FY21 revenue growth view to low teens 12/18/20 Nike reports Q2 inventories $6.1B, down 2% 12/18/20 Nike reports Q2 NIKE Brand revenue $10.7B, up 8% 12/18/20 Nike reports Q2 NIKE Direct sales $4.3B, up 32% NKE Nike $139.95 / -1.62 (-1.14%) 12/02/20 UPS imposes shipping restrictions on Gap, Nike, WSJ reports 08/22/20 These four stocks are Barron's plays on 'strange' back-to-school season 08/13/20 Apple plans to launch 'Apple One' subscription bundles, Bloomberg reports 07/28/20 Nike names new chief diversity officer, WSJ reports NKE Nike $139.95 / -1.62 (-1.14%) 12/21/20 Fly Intel: Wall Street's top stories for Monday 12/21/20 Fly Intel: Wall Street's top stories at midday 12/21/20 Fly Intel: Pre-market Movers 12/18/20 Fly Intel: What to watch in Nike's earnings report NKE Nike $139.95 / -1.62 (-1.14%) 12/21/20 Early notable gainers among liquid option names on December 21st 12/18/20 Nike options imply 8.7% move in share price post-earnings 11/10/20 Nike call volume above normal and directionally bullish 09/24/20 Unusually active option classes on open September 24th

Technical Analysis	NASDAQ market internals summary » 11:17 01/22/21 01/22 11:17 01/22/21 11:17 $NSD NASDAQ Market Internals $0.00 / + (+0.00%) Volume is above average… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Technical Analysis $NSD NASDAQ Market Internals $0.00 / + (+0.00%) 10:17 Today NASDAQ market internals summary 01/21/21 NASDAQ market internals summary 01/21/21 NASDAQ market internals summary 01/21/21 NASDAQ market internals summary
Technical Analysis	NYSE market internals summary » 11:16 01/22/21 01/22 11:16 01/22/21 11:16 $NYE NYSE Market Internals $0.00 / + (+0.00%) Volume is above average… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Technical Analysis $NYE NYSE Market Internals $0.00 / + (+0.00%) 10:16 Today NYSE market internals summary 01/21/21 NYSE market internals summary 01/21/21 NYSE market internals summary 01/21/21 NYSE market internals summary
Options	STMicroelectronics put volume heavy and directionally bearish » 11:15 01/22/21 01/22 11:15 01/22/21 11:15 STM STMicroelectronics $39.80 / -0.74 (-1.83%) Bearish flow noted in… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options STM STMicroelectronics $39.80 / -0.74 (-1.83%) 01/11/21 STMicroelectronics appoints Rajita D'Souza as president, HR 12/14/20 STMicroelectronics joins Ultra Wide Band Alliance 12/14/20 STMicroelectronics partners with Schneider Electric on carbon neutrality 12/10/20 STMicroelectronics, Microsoft partner for smart-appliance controllers STM STMicroelectronics $39.80 / -0.74 (-1.83%) 01/14/21 Barclays STMicroelectronics price target raised to EUR 40 from EUR 36 at Barclays 01/13/21 UBS STMicroelectronics downgraded to Neutral from Buy at UBS 01/12/21 Deutsche Bank STMicroelectronics price target raised to EUR 39 from EUR 35 at Deutsche Bank 01/12/21 Societe Generale STMicroelectronics price target raised to EUR 41 from EUR 35 at Societe Generale STM STMicroelectronics $39.80 / -0.74 (-1.83%) 01/08/21 STMicroelectronics reports preliminary Q4 revenue $3.24B, consensus $3.01B 10/22/20 STMicroelectronics sees Q4 revenue $2.99B, consensus $2.77B 10/22/20 STMicroelectronics reports Q3 EPS 26c, consensus 28c 10/01/20 STMicroelectronics reports Q3 preliminary revenue $2.67B, consensus $2.47B STM STMicroelectronics $39.80 / -0.74 (-1.83%) 01/12/21 On, Lumentum seen among top semiconductors takeout candidates for 2021 01/08/21 Fly Intel: Pre-market Movers 01/28/21 STMicroelectronics - STM STM STMicroelectronics $39.80 / -0.74 (-1.83%) 01/06/21 STMicroelectronics call volume above normal and directionally bullish 12/15/20 STMicroelectronics call volume above normal and directionally bullish 12/01/20 STMicroelectronics call volume above normal and directionally bullish 10/26/20 STMicroelectronics put volume heavy and directionally bearish
Recommendations	NorthWest Healthcare price target raised to C$13.50 from C$13 at National Bank » 11:13 01/22/21 01/22 11:13 01/22/21 11:13 NWHUF NorthWest Healthcare $0.00 / + (+0.00%) National Bank analyst Tal… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research NWHUF NorthWest Healthcare $0.00 / + (+0.00%) 11/18/20 National Bank NorthWest Healthcare price target raised to C$13 from C$11.50 at National Bank 11/18/20 RBC Capital NorthWest Healthcare price target raised to C$13 from C$12 at RBC Capital 11/17/20 Scotiabank NorthWest Healthcare price target raised to C$13.50 from C$12.75 at Scotiabank 08/31/20 BMO Capital NorthWest Healthcare price target raised to C$13.25 from C$11.50 at BMO Capital
Recommendations	American Hotel Income Properties price target raised to C$3.50 at National Bank » 11:13 01/22/21 01/22 11:13 01/22/21 11:13 AHOTF American Hotel Income Properties $0.00 / + (+0.00%) National Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research AHOTF American Hotel Income Properties $0.00 / + (+0.00%) 11/20/20 Scotiabank American Hotel Income Properties price target raised to C$3.25 at Scotiabank 09/08/20 BMO Capital American Hotel Income Properties price target lowered to C$2.50 at BMO Capital 08/18/20 Scotiabank American Hotel Income Properties price target lowered to C$2.25 at Scotiabank 08/10/20 Canaccord American Hotel Income Properties price target lowered to C$3 at Canaccord

Recommendations	Inovalis Real Estate price target raised to C$10 from C$9.50 at National Bank » 11:11 01/22/21 01/22 11:11 01/22/21 11:11 IVREF Inovalis Real Estate $0.00 / + (+0.00%) National Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research IVREF Inovalis Real Estate $0.00 / + (+0.00%) 11/18/20 Canaccord Inovalis Real Estate price target raised to C$9.50 from C$9.25 at Canaccord 11/17/20 National Bank Inovalis Real Estate price target raised to C$9.50 from C$8.75 at National Bank 11/16/20 BMO Capital Inovalis Real Estate price target raised to C$8.50 from C$7.50 at BMO Capital 08/17/20 BMO Capital Inovalis Real Estate price target raised to C$7.50 from C$7 at BMO Capital
Recommendations	BSR REIT price target raised to $13 from $12.50 at National Bank » 11:10 01/22/21 01/22 11:10 01/22/21 11:10 BSRTF BSR REIT $0.00 / + (+0.00%) National Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research BSRTF BSR REIT $0.00 / + (+0.00%) 08/18/20 RBC Capital BSR REIT price target raised to $12 from $11 at RBC Capital 08/17/20 BMO Capital BSR REIT price target raised to C$11.85 from C$11 at BMO Capital 05/20/20 BMO Capital BSR REIT price target lowered to C$11 from C$11.30 at BMO Capital 04/09/20 RBC Capital BSR REIT price target lowered to $11 from $13 at RBC Capital
Recommendations	InterRent REIT price target raised to C$15.50 from C$15 at National Bank » 11:09 01/22/21 01/22 11:09 01/22/21 11:09 IIPZF InterRent REIT $0.00 / + (+0.00%) National Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research IIPZF InterRent REIT $0.00 / + (+0.00%) 01/12/21 Raymond James InterRent REIT price target raised to C$16.50 from C$15.50 at Raymond James 11/11/20 RBC Capital InterRent REIT upgraded to Outperform from Sector Perform at RBC Capital 11/10/20 CIBC InterRent REIT price target lowered to C$14.50 from C$16 at CIBC 11/10/20 Canaccord InterRent REIT price target lowered to C$15.75 from C$16.50 at Canaccord
Recommendations	BTB REIT price target raised to C$3.75 from C$3.50 at National Bank » 11:08 01/22/21 01/22 11:08 01/22/21 11:08 BTBIF BTB REIT $0.00 / + (+0.00%) National Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research BTBIF BTB REIT $0.00 / + (+0.00%) 11/12/20 National Bank BTB REIT price target raised to C$3.50 from C$3.30 at National Bank 11/11/20 Industrial Alliance BTB REIT upgraded to Buy from Hold at Industrial Alliance 10/14/20 National Bank BTB REIT resumed with a Sector Perform at National Bank 05/20/20 National Bank BTB REIT price target lowered to C$3 from C$3.25 at National Bank
Syndicate	Jack Creek Investment opens at $10.40, IPO priced at $10 » 11:07 01/22/21 01/22 11:07 01/22/21 11:07 JCIC Jack Creek Investment $0.00 / + (+0.00%) Jack Creek Investment… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial

Events

Earnings calls, analyst events, roadshows and more

WAL
Today at 12:00

Western Alliance - WAL Conference Calls
Today at 12:00

Autos & Auto Parts Industry Meetings
FHB
Today at 13:00

First Hawaiian - FHB Conference Calls
ACBI
Today at 13:00

Atlantic Capital - ACBI Conference Calls
BIOL
Today at 14:00

Biolase Inc. Firm Sponsored Meetings

27042 Towne Centre Dr Suite 270, Foothill Ranch, CA
Tomorrow at 00:00

2021 VESS Annual Winter Meeting Conferences

Virtual Meeting
PFE
2021-01-24 at 00:00

PDUFA Date for Xalkori (Crizotinib) - January 2021 Government Event
2021-01-24 at 00:00

2021 VESS Annual Winter Meeting Conferences

Virtual Meeting
2021-01-25 at 00:00

Annual Virtual Washington DC Energy & Power Policy Field Trip Conferences

Virtual Field Trip
NBAC
2021-01-25 at 00:00

Newborn Acquisition Corp. Firm Sponsored Meetings

Virtual Meeting

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	BDGE X BDGE Bridge Bancorp Block Trade Managers: Morgan Stanley Priced at: $25.50 700K Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TCRR X TCRR TCR2 Therapeutics Secondary Managers: Goldman Sachs, Jefferies, Piper Sandler & BMO Capital Priced at: $30.50 4.59M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ACRS X ACRS Aclaris Therapeutics Spot Secondary Managers: Cantor Fitzgerald & William Blair, H.C. Wainwright Priced at: $17.50 5.484M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ACRX X ACRX AcelRx Spot Secondary Managers: Cantor Fitzgerald Priced at: $1.90 14.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BLRX X BLRX BioLineRx Spot Secondary Managers: H.C. Wainwright Priced at: $2.40 12.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BNGO X BNGO Bionano Genomics Spot Secondary Managers: Oppenheimer, BTIG, Ladenburg, Maxim Priced at: $6.00 33.333M Shares DSS X DSS Document Security Spot Secondary Managers: Aegis Priced at: $3.60 6.67M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FULC X FULC Fulcrum Therapeutics Spot Secondary Managers: SVB Leerink, Piper Sandler & Credit Suisse Priced at: $11.00 4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial LAC X LAC Lithium Americas Spot Secondary Managers: Canaccord, Deutsche Bank, Evercore ISI, Stifel Priced at: $22.00 15.9M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PERI X PERI Perion Network Spot Secondary Managers: Oppenheimer, Stifel, Roth Capital, LAKE Priced at: $11.50 4.99M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SYRS X SYRS Syros Pharmaceuticals Spot Secondary Managers: Cowen & Piper Sandler Priced at: $14.00 5.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	DFH X DFH Dream Finders Homes IPO Managers: BofA, RBC Capital & BTIG, Builder Advisor, Zelman, TCB Capital, Wedbush Priced at: $13.00 9.6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MYTE X MYTE Mytheresa IPO Managers: Morgan Stanley & JPMorgan, Credit Suisse, UBS, Jefferies, Cowen Priced at: $26.00 15.647M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ATHA X ATHA Athira Pharma Secondary Managers: Goldman Sachs, Jefferies, Stifel & JMP Securities Priced at: $22.50 4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CDNA X CDNA CareDx Secondary Managers: Goldman Sachs & Jefferies, Raymond James, BTIG, Craig-Hallum, H.C. Wainwright Priced at: $91.00 1.923M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CMRX X CMRX Chimerix Secondary Managers: Jefferies & Cowen, H.C. Wainwright, JonesTrading Priced at: $8.50 11.765M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CTMX X CTMX CytomX Therapeutics Secondary Managers: JPMorgan, Cowen & Piper Sandler Priced at: $7.00 14.286M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DYN X DYN Dyne Therapeutics Secondary Managers: JPMorgan, Jefferies, Piper Sandler & Stifel Priced at: $28.00 6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial EDIT X EDIT Editas Medicine Secondary Managers: JPMorgan & Morgan Stanley, Cowen, Credit Suisse Priced at: $66.00 3.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MRUS X MRUS Merus Secondary Managers: Jefferies & SVB Leerink Priced at: $24.75 4.85M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CYRX X CYRX Cryoport Spot Secondary Managers: Morgan Stanley, Jefferies, SVB Leerink & UBS Priced at: $66.00 3.788M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial INO X INO Inovio Spot Secondary Managers: BofA, Jefferies & Cantor Fitzgerald, Oppenheimer Priced at: $8.50 2.655M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ONCS X ONCS OncoSec Spot Secondary Managers: BTIG Priced at: $5.45 7.71M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ORC X ORC Orchid Island Capital Spot Secondary Managers: JPMorgan Priced at: $5.30 7.6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	VRAY X VRAY ViewRay Block Trade Managers: Morgan Stanley Priced at: $4.75 11.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PAX X PAX Patria IPO Managers: JPMorgan, BofA & Credit Suisse, Goldman Sachs, Bradesco BBI, BTG Pactual, ITAU, Keefe Bruyette, Santander, XP Priced at: $17.00 30.099M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RLX X RLX RLX Technology IPO Managers: Citi, China Renaissance Priced at: $12.00 116.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AZEK X AZEK Azek Secondary Managers: Barclays, BofA, Goldman Sachs & Jefferies Priced at: $40.00 20M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CRSR X CRSR Corsair Gaming Secondary Managers: Goldman Sachs, Barclays, Credit Suisse, Macquarie, Baird, Cowen & Stifel, Wedbush, Academy Securities Priced at: $35.00 7.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DCBO X DCBO Docebo Secondary Managers: Morgan Stanley, Goldman Sachs & Canaccord Priced at: $49.67 2.013M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial NVTA X NVTA Invitae Secondary Managers: JPMorgan, Morgan Stanley, Cowen & SVB Leerink Priced at: $51.50 7.77M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PASG X PASG Passage Bio Secondary Managers: JPMorgan, Goldman Sachs & Cowen, Wedbush, Chardan Priced at: $22.00 7M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SI X SI Silvergate Capital Secondary Managers: Goldman Sachs, Keefe Bruyette & Canaccord, Compass Point, Craig-Hallum Priced at: $63.00 3.968M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ACB X ACB Aurora Cannabis Spot Secondary Managers: BMO Capital, ATB Capital Markets Priced at: $10.45 12M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial GSL X GSL Global Ship Lease Spot Secondary Managers: Jefferies & B. Riley Securities Priced at: $13.00 5.384M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PGEN X PGEN Precigen Spot Secondary Managers: Wells Fargo & Stifel, JMP Securities, H.C. Wainwright Priced at: $7.50 15M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SENS X SENS Senseonics Spot Secondary Managers: H.C. Wainwright Priced at: $1.925 51.9M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

View All Syndicate Announcements »

Humana initiated with a Buy at Goldman Sachs

TODAY'S FREE FLY STORIES

Get Full Fly Access